Table 3.
Apparent Cause of Death in Control and Rapamycin-Treated Mice
Number of cases |
Percent of cases |
Mean age at death |
||||
Diagnosis | Control | Rapamycin | Control | Rapamycin | Control | Rapamycin |
Adrenal carcinoma | 2 | 4 | ||||
Cardiac fibrosis | 1 | 2 | ||||
Cardiomyopathy | 1 | 2 | ||||
Fibrosarcoma | 3 | 1 | 7 | 2 | ||
Hemangiosarcoma | 10 | 6 | 22 | 14 | 884 | 890 |
Hydronephrosis | 1 | 2 | ||||
Liposarcoma | 1 | 2 | ||||
Liver carcinoma | 2 | 4 | 4 | 9 | 841 | 1006 |
Lung carcinoma | 7 | 15 | 15 | 34 | 755 | 1004 |
Lymphoma | 15 | 8 | 33 | 18 | 920 | 951 |
Mammary carcinoma | 4 | 2 | 9 | 5 | 826 | 1142 |
Melanoma | 1 | 2 | ||||
Mouse urinary syndrome | 1 | 2 | ||||
Nephritis | 1 | 2 | ||||
Septicemia | 1 | 2 | ||||
Skin carcinoma | 1 | 2 | ||||
Thymoma | 1 | 2 | ||||
Thyroid carcinoma | 1 | 2 | ||||
Total diagnosable cases | 46 | 44 |
Note: Mean age at death is calculated for those diagnostic categories with at least two cases in each of the two groups of mice.